Supply Agreement NR
Aphria to supply pot to Argentine importer
2018-03-21 09:08 ET - News Release
Mr. Vic Neufeld reports
APHRIA SIGNS EXCLUSIVE AGREEMENT WITH ARGENTINA-BASED IMPORTER TO SUPPLY MEDICAL CANNABIS IN ARGENTINA
Aphria Inc. has signed an exclusive supply agreement with an Argentina-based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical products and derivatives in Argentina. The importer is currently securing an import licence for cannabis in Argentina.
"We are excited to enter the Argentinian market through this initial supply agreement," said Vic Neufeld, chief executive officer of Aphria. "We see tremendous potential for medical cannabis in several emerging markets in South America, including Argentina. As the leading low-cost supplier of high-quality medical cannabis, Aphria will continue to expand its global leadership through strategic investments, partnerships and exclusive agreements such as this one."
Under the terms of the agreement, Aphria will be the exclusive supplier of cannabis products to the importer for the Argentine market. At the importer's request, financial terms and the name of the importer of the agreement are not being released.
Aphria has a good thing growing.
About Aphria Inc.
Aphria, one of Canada's lowest-cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ont., the greenhouse capital of Canada, Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care, while balancing patient economics and returns to shareholders.
We seek Safe Harbor.